-
EP0745077
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0745077
| EP0745077 - ENANTIOMERICALLY PURE (+)-LIAROZOLE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.08.1998 Database last updated on 15.06.2024 | Most recent event Tooltip | 07.08.1998 | Application deemed to be withdrawn | published on 23.09.1998 [1998/39] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [1996/49] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30 B-2340 Beerse / BE | Inventor(s) | 01 /
VENET, Marc, Gaston 10, square de Bourgogne F-76240 Le Mesnil-Esnard / FR | [1996/49] | Representative(s) | Quaghebeur, Luc, et al Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [1996/49] | Quaghebeur, Luc, et al Janssen Pharmaceutica N.V., Patent Department, Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 95907662.1 | 10.02.1995 | [1996/49] | WO1995EP00490 | Priority number, date | EP19940200420 | 18.02.1994 Original published format: EP 94200420 | [1996/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9522540 | Date: | 24.08.1995 | Language: | EN | [1995/36] | Type: | A1 Application with search report | No.: | EP0745077 | Date: | 04.12.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.08.1995 takes the place of the publication of the European patent application. | [1996/49] | Search report(s) | International search report - published on: | EP | 24.08.1995 | Classification | IPC: | C07D403/06, C07D233/16, A61K31/415 | [1996/49] | CPC: |
C07D249/08 (EP);
A61P17/00 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07D231/12 (EP);
C07D233/56 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1996/49] | Extension states | LT | 18.09.1996 | SI | 18.09.1996 | Title | German: | ENANTIOMERREINE (+)- LIAROZOLE | [1996/49] | English: | ENANTIOMERICALLY PURE (+)-LIAROZOLE | [1996/49] | French: | (+)- LIAROZOLE PUR SUR LE PLAN ENANTIOMORPHE | [1996/49] | Entry into regional phase | 18.09.1996 | National basic fee paid | 18.09.1996 | Designation fee(s) paid | 18.09.1996 | Examination fee paid | Examination procedure | 12.09.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 18.09.1996 | Examination requested [1996/49] | 18.09.1997 | Despatch of a communication from the examining division (Time limit: M06) | 31.03.1998 | Application deemed to be withdrawn, date of legal effect [1998/39] | 29.04.1998 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1998/39] | Fees paid | Renewal fee | 28.02.1997 | Renewal fee patent year 03 | 02.03.1998 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]EP0260744 (JANSSEN PHARMACEUTICA NV [BE]) [YD] 1-12 * see: example 11a3 and page 26, line 16 and compound no. 133; example 30 and page 38, ** line 32 and page 39, compound 187 *; | [YD]EP0371559 (JANSSEN PHARMACEUTICA NV [BE]) [YD] 1-12 * see: table 1, compound 28; page 9, line 57 - page 10, line 12; page 12, lines 33-46; * * page 30, lines 30-48 * |